Home
User Profile
  • 09/2004 – 07/2009 Bachelor/MD equivalent, Clinical Medicine, Jiangsu University Medical School, Zhenjiang, Jiangsu, China
  • 09/2009 – 07/2013 Master/MD, Department of Neurosurgery, Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, China
  • 03/2017 – 11/2018 PhD, Department of Neurosurgery, Southeast University, Zhongda Hospital affiliate to Southeast University, Nanjing, Jiangsu, China
  • 11/2018 – Present Visiting Research Scientist, Massachusetts General Hospital, Boston, MA
  • 1. Chen W, Yang Y. et al. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells. J Neurooncol. 2014 Oct;120(1):43-53.
  • 2. Chen W, Yu Q, et al. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients. Oncotarget. 2016 Aug 16;7(33):53392-53413.
  • 3. Zhang R, Chen W. et al. MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1. Neuro Oncol. 2014 Nov;16(11):1510-22 (Co-first author)
  • 4. Luo H, Chen W, et al. c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma. Brain. 2015 Dec;138(Pt12):3654-72. (Co-first author)
  • Mechanisms by which intravenously administered exosomes (extracellular vesicles) derived from mesenchymal stem cells (MSCs) or human neural stem cells (hNSCs) promote neuroprotection, in models of stroke.